Transmembrane Interactions Are Needed for KAI1/CD82-Mediated Suppression of Cancer Invasion and Metastasis
- 28 February 2009
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 174 (2), 647-660
- https://doi.org/10.2353/ajpath.2009.080685
Abstract
In transmembrane (TM) domains, tetraspanin KAI1/CD82 contains an Asn, a Gln, and a Glu polar residue. A mutation of all three polar residues largely disrupts the migration-, invasion-, and metastasis-suppressive activities of KAI1/CD82. Notably, KAI1/CD82 inhibits the formation of microprotrusions and the release of microvesicles, while the mutation disrupts these inhibitions, revealing the connections of microprotrusion and microvesicle to KAI1/CD82 function. The TM polar residues are needed for proper interactions between KAI1/CD82 and tetraspanins CD9 and CD151, which also regulate cell movement, but not for the association between KAI1/CD82 and alpha3beta1 integrin. However, KAI1/CD82 still efficiently inhibits cell migration when either CD9 or CD151 is absent. Hence, KAI1/CD82 interacts with tetraspanin and integrin by different mechanisms and is unlikely to inhibit cell migration through its associated proteins. Moreover, without significantly affecting the glycosylation, homodimerization, and global folding of KAI1/CD82, the TM interactions maintain the conformational stability of KAI1/CD82, evidenced by the facts that the mutant is more sensitive to denaturation and less associable with tetraspanins and supported by the modeling analysis. Thus, the TM interactions mediated by these polar residues determine a conformation either in or near the tightly packed TM region and this conformation and/or its change are needed for the intrinsic activity of KAI1/CD82. In contrast to immense efforts to block the signaling of cancer progression, the perturbation of TM interactions may open a new avenue to prevent cancer invasion and metastasis.Keywords
This publication has 56 references indexed in Scilit:
- Integrity of all four transmembrane domains of the tetraspanin uroplakin Ib is required for its exit from the ERJournal of Cell Science, 2006
- The Structure of the ζζ Transmembrane Dimer Reveals Features Essential for Its Assembly with the T Cell ReceptorCell, 2006
- KAI1/CD82, a tumor metastasis suppressorCancer Letters, 2006
- Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-Å resolutionThe Journal of cell biology, 2006
- A Critical Role for Tetraspanin CD151 in α3β1 and α6β4 Integrin–dependent Tumor Cell Functions on Laminin-5Molecular Biology of the Cell, 2006
- CD82 metastasis suppressor gene: a potential target for new therapeutics?Trends in Molecular Medicine, 2005
- The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory ActivityCancer Research, 2004
- Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linkingBiochemical Journal, 2004
- Requirement of the p130CAS-Crk Coupling for Metastasis Suppressor KAI1/CD82-mediated Inhibition of Cell MigrationPublished by Elsevier BV ,2003
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003